Skip to main content
background gradient

Volume 6Issue 1

Foreword

Editorial

From Methods to Policy

Interview

Free Access
Healthcare reform in the Middle East and the USA
  • Mustafa Z Younis
pp13–14
Published Online:9 December 2016
Preview Abstract

Research Article

Free Access
Burden of illness and research investments in translational sciences for pharmaceuticals in metastatic cancers
  • Wei-Jhih Wang,
  • Justin C Robertson, and
  • Anirban Basu
pp15–24
Published Online:9 December 2016
Preview Abstract
Free Access
Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk
  • James H Flory,
  • Jason Roy,
  • Joshua J Gagne,
  • Kevin Haynes,
  • Lisa Herrinton,
  • Christine Lu,
  • Elisabetta Patorno,
  • Azadeh Shoaibi, and
  • Marsha A Raebel
pp25–32
Published Online:9 December 2016
Preview Abstract
Free Access
Adverse effects of carbamazepine monotherapy among patients in Nigeria: a pilot study and implications
  • Adedunni Olusanya,
  • Olayinka Ogunleye,
  • Brian Godman,
  • Joseph Fadare, and
  • Mustafa Danesi
pp33–42
Published Online:12 December 2016
Preview Abstract

Perspective

Free Access
HIV, breast cancer and vaccines: what do high-profile cases reveal about stakeholder engagement in research?
  • Stephanie R Morain,
  • Thomas W Concannon, and
  • Eve Wittenberg
pp43–49
Published Online:2 September 2016
Preview Abstract

Review

Free Access
Barriers to evidence-based physician decision-making at the point of care: a narrative literature review
  • Kara Contreary,
  • Anna Collins, and
  • Eugene C Rich
pp51–63
Published Online:9 December 2016
Preview Abstract

Systematic Review

Free Access
Do disparities between populations in randomized controlled trials and the real world lead to differences in outcomes?
  • Emma Gray,
  • Suzanne Norris,
  • Susanne Schmitz, and
  • Aisling O'Leary
pp65–82
Published Online:17 November 2016
Preview Abstract